Searched for: summary statement gynaecomastia
-
ABS Summary Statement: Investigation and management of gynaecomastia in primary and secondary care
The Association of Breast Surgery has produced clinical guidance for the investigation and management of gynaecomastia. There are recommendations for appropriate investigation of patients and recommended referral pathways to ensure most appropriate careRead More chevron_right -
Gynaecomastia Infographic for Primary Care
The Royal College of General Practitioners have endorsed the ABS infographic for the assessment and referral of gynaecomastia patients in Primary Care. ABS members are welcome to download this infographic and share amongst primary and secondary care colleagues. The infographic supplements the ABS Summary Statement: Investigation and management of gynaecomastia in primary and secondary careRead More chevron_right -
ABS Summary Statement: Update on optimal duration of adjuvant antihormonal therapy
The guidance from NICE is now dated. Updates are awaited from NICE or the UK Breast Cancer Group on current developments. In the meantime, following a review of all published data, ABS have produced a summary statement to help guide adjuvant hormonal therapy in appropriate patientsRead More chevron_right -
Gynaecomastia
Read More chevron_right -
ABS Summary Statement: Management of fibroadenomas
This guidance document on the management of fibroadenomas has been produced by the ABS with the involvement of representatives from the British Society of Breast Radiologists and the National Coordinatin Committee of Breast PathologyRead More chevron_right -
ABS Summary Statement: Breast operation note documentation
Read More chevron_right -
ABS Summary Statement: Consent Best Practice
The principle of consent is an important part of medical ethics and human rights law. The ABS' Clinical Practice & Standards Committee has produced this best practice guidance for its membersRead More chevron_right -
ABS Summary Statement: Writing Letters to Patients
Following the Paterson inquiry in 2021, the Department of Health recommended that clinicians write directly to patients after clinic visits. This document offers the rationale behind this decision and offers guidance on how to integrate this method of communication into day to day practice.Read More chevron_right -
ABS Summary Statement: Use of Blue Dye for SLNB
Read More chevron_right -
ABS Summary Statement: Guidelines on antibiotic prophylaxis in breast surgery
Read More chevron_right -
ABS Summary Statement: Breast Implant Associated-Anaplastic Lymph Cell Lymphoma
Read More chevron_right -
ABS Summary Statement: Contralateral mastectomy for unilateral breast cancer
Read More chevron_right -
Postoperative radiotherapy for breast cancer: UK consensus statement
This UK wide guidance is produced by the Clinical Oncology Group of the Royal College of Radiologists and is supported by ABS. It includes statements on axillary and internal mammary lymph node radiotherapy and adjuvant radiotherapy following breast conserving surgeryRead More chevron_right -
ABS Summary Statement: Duration and frequency of surveillance mammography after primary breast cancer treatment
Read More chevron_right -
ABS Summary Statement: Overview of the implications and implementation of NICE guidelines on Familial Breast Cancer
This overview summarises the NICE guidance but also discusses what needs to be put in place in secondary care to provide the service. There is a clear discussion of the Manchester Scoring System to calculate risk. It is a useful articles to read for a clear understanding of screening, chemoprevention and risk reducing surgeryRead More chevron_right -
ABS Summary Statement: Guidelines for the investigation and management of spontaneous nipple discharge in the absence of a breast lump
This guidance document on the management of nipple discharge has been produced by the ABS with the involvement of representatives from the British Society of Breast Radiologists and the National Coordinating Committee of Breast PathologyRead More chevron_right -
Sentinel Lymph node biopsy for patients with early stage breast cancer update
The ASCO recommendations are similar to those proposed in the ABS Summary Statement: Management of the Malignant Axilla in Early Breast Cancer and are supported by the ABS.Read More chevron_right -
Mammary Fold
The Mammary Fold website is great resource for all trainees interested in becoming or training as a breast surgeon. We would encourage you to engage with the Mammary Fold Committee and Regional Representatives to ensure the Mammary Fold can represent all breast trainees in the UK.
Medical students and FY 1 & 2 doctors can get involved with the Mammary Fold through our Junior Network and membership of the Mammary Fold itself is free for trainees up to ST3.
Members can register for Mammary Fold and ABS events at discounted rates.
Read More chevron_right -
Inaugural Mammary Fold Trainer of the Year Award Winner
We are delighted to announce the winner of the inaugural Mammary Fold Trainer of the Year Award.Read More chevron_right -
Covid-19: Statement from the ABS President (December 2021)
The ABS issued statements throughout the pandemic to support their members in delivering serviceRead More chevron_right -
Covid-19: Statement from the ABS President (September 2021)
The ABS issued statements throughout the pandemic to support their members in delivering servicesRead More chevron_right -
ABS & BAPRAS Joint Statement on Breast Reconstruction
A joint statement on breast reconstruction from ABS & BAPRASRead More chevron_right -
ABS Statement re COVID 19
The ABS issued a statement for its members in relation to COVID 19 on the 15th March 2020Read More chevron_right -
Updated statement on Breast Implant Safety
The ABS, BAAPS, BAPRAS and MHRA released the following statement on breast implant safety on the 4th April 2019.Read More chevron_right -
Contralateral Prophylactic Mastectomy Consensus Statement & Contralateral Prophylactic Mastectomy: Shared Decision Making
The American Society of Breast Surgery have produced a comprehensive review of the literature on Contralateral Mastectomy in patients with unilateral cancers (called prophylactic mastectomy in their papers). There is also a paper on shared decision making with patients. The cost of surveillance versus surgery and the psychosocial impact of surgery and the importance of shared decision making are discussed. ABS supports the advice contained in the above document. There is also an ABS summary statement designed to help the decision making process for surgeons which can be found elsewhere in this section.Read More chevron_right -
Covid-19: ABS Statement (March 2020)
The ABS issued a statement for its members on the 15th March 2020 in relation to Covid-19. This statement subsequently received the approval of the UKBCG.Read More chevron_right -
Statement on NHS Screening and GP Registrations issue
ABS statement on the recent GP registration and NHS screening issue.Read More chevron_right -
Inaugural Mammary Fold Trainer of the Year Award 2025 - Nominations are open
The Mammary Fold is now in search of the most accomplished trainer to receive this inaugural award.Read More chevron_right -
ABS Statement on the Report of the Independent Inquiry into the issues raised by Paterson
The ABS released a statement on the 4th February 2020Read More chevron_right -
Covid-19: ABS Statement (April 2020)
In April 2020 the ABS issued an updated statement in relation to the delivery of breast services during the Covid-19 pandemicRead More chevron_right -
Covid-19: ABS Statement (January 2021)
On the 5th January 2021 the ABS released a further statement in relation to the Covid-19 pandemicRead More chevron_right -
Urgent Update on PIP Implants: Statement by Andrew Lansley, Secretary of State
The following statement has been released on Friday 6th January 2012.Read More chevron_right -
Covid-19: Joint statement from the ABS & UKBCG on Neoadjuvant Chemotherapy
The UKBCG and ABS released a joint statement on neoadjuvant chemotherapy during the Covid-19 pandemicRead More chevron_right -
ABS statement on the role of the physician’s associate (PA) within the breast team
The ABS issued a statement on the role of PAs within the breast team on the 9th September 2024Read More chevron_right -
Medicines and Healthcare products Regulatory Agency (MHRA) statement on BIA-ALCL
On Wednesday 26th July 2017 the MHRA released a statement on Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL).Read More chevron_right -
ABS statement on the role of the physician’s associate (PA) within the breast team
The ABS issued a statement on the role of PAs within the breast team on the 9th September 2024Read More chevron_right -
Tripartite Statement on PIP Implants from the ABS, BAAPS and BAPRAS
The following statement has been issued on the 5th January 2012 by the Association of Breast Surgery, the British Association of Aesthetic Plastic Surgeons and the British Association of Plastic, Reconstructive and Aesthetic Plastic Surgeons:Read More chevron_right -
ABS Consensus Statement: Margin width in breast conservation surgery
NICE recommends re-excision of breast tissue if radial margin of excision is less than 2mm. A similar conclusion is presented by ASCO. Following a literature review, the consensus statement from ABS is that, if excision of DCIS with a margin of 1mm or greater is achieved, routine re-excision is not warranted. This consensus statement can be found on the ABS guidance page under “Cancer Surgery”.Read More chevron_right -
Privacy Statement
This privacy policy describes how the Association of Breast Surgery (ABS) protects and makes use of the information given by its members.Read More chevron_right -
Management of Breast Cancer in the Older Patient: Summary
Read More chevron_right -
Consensus statement and close of meeting
Read More chevron_right -
ABS statement on cosmetic tourism
ABS welcomes call for collaboration to protect those thinking about traveling overseas for surgery.Read More chevron_right -
Introduction and update from the Mammary Fold
Read More chevron_right -
BMS Consensus Statement: The risks & benefits of HRT before and after a breast cancer diagnosis
Questions regarding the risk/ benefits of Hormone Replacement Therapy (HRT) are common in breast clinics. The British Menopause Society (BMS) have produced a clear and helpful document which summarises the latest thinking on this topic. The risks of HRT are compared with other lifestyle factors such as alcohol, exercise etc. The Consensus Statement was updated in February 2020 The BMS website is itself a useful resource, which can be accessed by ABS members for freeRead More chevron_right -
BMS Consensus Statement: The risks & benefits of HRT before and after a breast cancer diagnosis
Questions regarding the risk/ benefits of Hormone Replacement Therapy (HRT) are common in breast clinics. The British Menopause Society (BMS) have produced a clear and helpful document which summarises the latest thinking on this topic. The risks of HRT are compared with other lifestyle factors such as alcohol, exercise etc. The Consensus Statement was updated in February 2020 The BMS website is itself a useful resource, which can be accessed by ABS members although some content is for BMS members onlyRead More chevron_right -
ABS Statement on Surgical Care Practitioners
Association of Breast Surgery’s response to concerns to SCPs performing independent surgery.Read More chevron_right -
ABS Statement on Surgical Care Practitioners
Association of Breast Surgery’s response to concerns to SCPs performing independent surgery.Read More chevron_right -
Research
The MFAC is a subcommittee of the Mammary Fold interested in supporting and delivering collaborative audit and research.Read More chevron_right -
Trainee Webinar: The Mammary Fold FRCS Part II
Read More chevron_right -
Internal mammary nodes in DIEP reconstruction: Do they matter?
Read More chevron_right -
Breast Cancer Screening Update: Written statement
Read More chevron_right -
ABS Statement regarding Mr Ian Paterson
Mr Ian Paterson FRCS, a general and breast surgeon, who worked at the NHS Solihull Hospital, Little Aston and Solihull Spire private hospitals, was suspended by the General Medical Council (GMC) in 2012 for performing ‘unnecessary' and 'inappropriate’ breast surgery on large numbers of women over many years.Read More chevron_right -
Mastitis and Mammary Abscess Management Audit (MAMMA) in the UK and Ireland
MAMMA describes the current practice in management of mastitis and breast abscess in UK and Ireland, with a specific focus on the rate of surgical intervention. From 69 participating hospitals, 1312 patient’s data were analysed (Aug 2020 to Aug 2021). Primary outcome measures included patient management pathway characteristics and treatment types (medical/radiological/surgical). MAMMA identified a high overall rate (21%) of breast abscess incision and drainage, and lower than anticipated rate of ultrasound-guided breast abscess aspiration (61%). Between individual units, significant variations were observed in the rate of incision and drainage (range 0–100%; P < 0.001) and needle aspiration (range 12.5–100%; P < 0.001). Overall requirement for inpatient treatment was 22.5%, with 72.9% of these patients requiring IV antibiotics. The odds of undergoing breast abscess incision and drainage or requiring inpatient treatments were significantly higher if patients presented at the weekend vs. weekday (P<0.023). Breast specialists reviewed 40.9% of all patients directly, despite the majority of study cohort (74.2%) presenting within weekday working hours.Read More chevron_right -
Breast Cancer Now summit statement on access to breast reconstruction
Read More chevron_right -
ABS Consensus Statement: Management of the Malignant Axilla in Early Breast Cancer
Read More chevron_right -
ABS statement on the call for evidence to shape the national cancer plan for England
The ABS responds to the recent call for evidence from the Department of Health and Social Care to help shape the government’s national cancer plan for England.Read More chevron_right -
Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk Reducing) Mastectomy
This document provides a comprehensive review of the evidence behind the surgical management of risk reducing and contralateral mastectomies. Evaluation of surgical techniques is included as are chemopreventative measures.Read More chevron_right -
Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement
Medication to Reduce Risk of Breast Cancer: USPS Task Force RecommendationRead More chevron_right -
Statement from Binita Ashar, M.D., of the FDA’s Center for Devices and Radiological Health on agency’s commitment to studying breast implant safety
A recent paper in the Annals of Surgery has looked at the long-term outcomes of breast implants in approximately 100,000 patients as part of the post approval studies.Read More chevron_right -
Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery (review)
The comprehensive review by the Cochrane team concludes that prophylactic antibiotics can reduce surgical site infection in breast cancer surgery. The Cochrane reviewers do not comment on antiobiotic usage in breast reconstruction patients. This topic is covered by the ABS Summary StatementRead More chevron_right -
Surveys
Read More chevron_right -
News
The latest news, updates and statements from the Association of Breast Surgery.Read More chevron_right -
PIP Implants: Updated Guidance
The ABS, BAPRAS, BAAPS, FSSA and Royal College of Surgeons have issued a joint surgical statment on clinical guidance for patients, GPs and surgeons on PIP implants.Read More chevron_right -
Christmas Mammary Fold webinar
Read More chevron_right -
Vacancies & Elections
Information about any vacancies for Mammary Fold rolesRead More chevron_right -
A brief history of Axillary Management
Professor John Benson provides a summary of how management of the axilla has changed in recent years and how it continues to evolve.Read More chevron_right -
Government response to the Paterson Inquiry
Mark Sibbering has compiled a very helpful summary of the Paterson Inquiry including the recommendations.Read More chevron_right -
The Surgical Royal Colleges and Surgical Specialty Associations of the UK and Ireland Reaffirm Standards for Cosmetic Surgery
Statement with regards the Cosmetic Surgery Certification SchemeRead More chevron_right -
Allergan Textured Breast Implants
The ABS issued the following statement on the 19th December 2018Read More chevron_right -
Session 17: Mammary Fold session
Read More chevron_right -
Mammary Fold Pre-ABS Meeting
Read More chevron_right -
Benefits of Adjuvant Bisphosphonates in Post menopausal women
The UK Breast Cancer Group have produced a very helpful 2 page summary of the benefits of bisphosphonates as adjuvant treatment in breast cancer patients.Read More chevron_right -
5th Mammary Fold Advance Communication Skills course
Read More chevron_right -
4th Mammary Fold Advance Communication Skills course
Read More chevron_right -
3rd Mammary Fold Advance Communication Skills course
Read More chevron_right -
The Mammary Fold annual survey results and actions
Read More chevron_right -
Session 14: Mammary Fold Posters Prize
Read More chevron_right -
Allergan Textured Breast Implants - advice to surgeons
The ABS has released the following statement on the 20th December 2018.Read More chevron_right -
Mastitis and Mammary Abscess Management Audit (MAMMA): A survey of patients’ perspective on the management of mammary abscesses in the UK
Read More chevron_right -
Contact Us
If you have an enquiry about the Mammary Fold, please get in touch using the relevant contact information below.Read More chevron_right -
About Us
The Mammary Fold is the national association run by trainees for trainees in breast and oncoplastic breast surgery in the UK.Read More chevron_right -
Covid-19: Running a breast service with ongoing Covid-19 restrictions: Recommendations from the ABS (October 2020)
In October 2020 the ABS released a further statement in relation to the delivery of breast cancer services during the Covid-19 pandemic.Read More chevron_right -
Covid-19: Moving forward - recommendations from the ABS on delivery of breast services during the Covid-19 pandemic (May 2020)
In May 2020 the ABS issued a further statement on breast services during the Covid-19 pandemicRead More chevron_right -
Specialty Status Application Update
Chris Holcombe, ABS President, issued a statement on the 11th April 2023 in relation to the application for specialty status for breast surgeryRead More chevron_right -
Courses & Events
For information about Mammary Fold & ABS courses and events please contact Margarita Bartholomew. T: 020 7869 6853 or 07936 359532 E: mbartholomew@absgbi.org.ukRead More chevron_right -
Breast implant safety
Joint statement: The Association of Breast Surgery (ABS) The British Association of Aesthetic Plastic Surgeons (BAAPS) The British Association of Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS)Read More chevron_right -
The diagnosis of the menopause and management of oestrogen deficiency symptoms and arthralgia in women treated for breast cancer
This comprehensive, evidence based consensus statement by the British Menopause Society, revised for the ABS, provides an overview of the management of women experiencing oestrogen deficiency symptoms and arthralgia following a breast cancer diagnosisRead More chevron_right -
SSO, ASRO, ASCO Consensus Guidelines on Margins for BCS with Whole Breast Irradiation in DCIS
NICE recommends re-excision of breast tissue if radial margin of excision is less than 2mm. A similar conclusion is presented by ASCO. Following a literature review the consensus statement from ABS is that, if excision of DCIS with a margin of 1mm or greater is achieved, routine re-excision is not warranted. This consensus statement can be found on the ABS guidance page under “Cancer Surgery”.Read More chevron_right -
Early and locally advanced breast cancer: diagnosis and treatment (CG80)
NICE recommends re-excision of breast tissue if radial margin of excision is less than 2mm. A similar conclusion is presented by ASCO. Following a literature review, the consensus statement from ABS is that, if excision of DCIS with a margin of 1mm or greater is achieved, routine re-excision is not warranted. This consensus statement can be found on the ABS guidance page under “Cancer Surgery”. The current recommendation by NICE is that further axillary treatment should be offered to women with micrometastases in sentinel lymph nodes. This differs from the recommendation by ABS, the European Society for Medical Oncology and the American Society for Clinical Oncology who advise against routine further axillary treatment in this group of patients. The ABS consensus statement on management of the malignant axilla can be found elsewhere in this section. The NICE guidance recommends that use of Adjuvant Online should be considered when planning adjuvant treatment for breast cancer patients. This is supported by ABS. Predict.nhs.uk is also a valuable tool for aiding adjuvant therapy decisionsRead More chevron_right -
Early and locally advanced breast cancer: diagnosis and treatment
NICE have updated their guidance on the management of early breast cancer to take into account developments since the 2009 iteration of this guidance. They recommend re-excision of breast tissue should be offered if DCIS or invasive cancer is present at the radial margins (tumour on ink). Re-excision should be considered if tumour is 0 to 2mm from radial margins. A similar conclusion is presented by ASCO. Following a literature review, the consensus statement from ABS is that, if excision of DCIS with a margin of 1mm or greater is achieved, routine re-excision is not warranted. This consensus statement can be found on the ABS guidance page under “Cancer Surgery”. Advice on breast reconstruction is now included in the guidance as is advice on extended endocrine therapy and lifestyle. Predict.nhs is recommended to aid decision making around adjuvant therapy and to estimate prognosis. There is no comment on tumour profiling tests to guide adjuvant chemotherapy decisions. The guidance around these is the subject of a separate NICE assessment process and will be published late 2018.Read More chevron_right -
Post-mastectomy radiotherapy
ASCO have produced recommendations on the requirements for postmastectomy chest wall irradiation in patients with T1-2 tumours and 1-3 positive axillary nodes or patients with a positive sentinel node who do not undergo further axillary surgery. Recommendations for axillary radiotherapy in patients who have received neoadjuvant systemic treatment and for irradiation of internal mammary nodes and the supraclavicular fossa are also presented. ABS supports this document and its use in the context of a multidisciplinary meetingRead More chevron_right -
The European Society of breast specialists recommendations for the management of young women with breast cancer
EUSOMA define “young” as age <40 and “very young” as age <35y. Their guidance gives a very good overview of the evidence surrounding the treatment of breast cancer in young women. This includes difficult issues such as sexual dysfunction, fertility preservation and bone health. The EUSOMA guidance also recommends margins of 2mm of more for DCIS. The ABS recommendation is 1mm or more and the ABS consensus statement on surgical margins can be found elsewhere in this sectionRead More chevron_right -
Women offered NHS breast screening after missed invitations
The following statement has been made by Public Health England: 'The decision follows analysis by Public Health England (PHE) dating back to 2009, which found that a number of invitations for a final test had not been sent out to women, between their 68th and 71st birthday. The total number of older women affected since 2009 is estimated to be approximately 450,000.Read More chevron_right
